•  
  •  
  •  
  •  

2026-07-22 03:04:56

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore

Keywords Selected:  APIFacility

Stock Report

  • Concord Biotech Ltd completes ANVISA Inspection conducted by the Brazilian Health Regulatory Agency at the Limbasi API Manufacturing Facility
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for facility at Panelav
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Concord Biotech Ltd successfully completes Russian GMP insepction at its API facility
  • Concord Biotech Ltd announces successful completion EU GMP inspection at its API facility
  • Concord Biotech Limited receives EIR from USFDA for API facility at Dholka
  • Unichem Laboratories Ltd receives Form 483 from USFDA with 3 observations for Roha API facility
  • Zydus receives EIR for the API manufacturing facility at Dabhasa
  • USFDA Inspection at Concord Biotech Ltd's API facility at Dholka
  • Nectar Lifesciences Limited receives 7 observations from EDQM for API facility
  • Unichem Laboratories Ltd receives 4 observations from USFDA for Pithampur API facility
  • Senores Pharmaceuticals begins operations at greenfield API facility
  • Bajaj Healthcare Ltd's API facility receives approval from TGA, Australia
  • Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA
  • Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility
  • Shivalik Rasayan Ltd's API facility gets 7 observations from USFDA
  • Concord Biotech Limited receives EUGMP certificate for Dholka facility
  • Zydus receives Post Application Action Letter for the USFDA cGMP nd Pre-Approval Inspection at the Ahmedabad API facility
  • EDQM conducts GMP inspection of SMS Pharmaceuticals Ltd's API facility
  • Bajaj Healthcare Ltd receives EIR from USFDA for API manufacturing facility in Savli
  • Shilpa Pharma Lifesciences Ltd, Unit II, Raichur, Karnataka has cleared PMDA Japan, GMP inspection
  • Smruthi Organics Ltd's API site completes inspection by South Korean regulator

Latest Post

  • CRISIL Limited Reports Q2 CY26 / Q1 FY27 Results: Consolidated Revenue Jumps 27.6% YoY to ₹1,075.39 Crore; Net Profit Reaches ₹216.46 Crore
  • Purple Finance Grants In-Principle Approval to Acquire 100% Stake in Saksham Gram Credit
  • InfoBeans Technologies Reports Q1 FY27 Results: Revenue Jumps 36.6% YoY to ₹152.77 Crore; Net Profit Stands at ₹21.62 Crore
  • Gamco Limited Reports Q1 FY27 Results: Consolidated Revenue Surges 105.8% YoY to ₹113.72 Crore; PAT Reaches ₹32.43 Crore
  • Gabriel India Reports Q1 FY27 Results: Consolidated Revenue Up 15.5% YoY to ₹1,425.68 Crore; Net Profit Reaches ₹108.13 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025